This is because Bacteroides fragilis abundance in the microbiome, the source of the neurotoxin BF-LPS, can be controlled by dietary fiber intake.
The team concluded that further research on this relationship could potentially lead to new diagnostic and therapeutic strategies in the clinical management of Alzheimer’s disease.
Gut microbiota is the scientific term for the microorganisms that live in the gut and include approximately 100 trillion organisms.
Together, these organisms play important roles in immunity, food digestion, metabolism, and neurological signaling, among other biological processes.
Previous analyzes of the gut microbiome in people with Alzheimer’s disease have revealed a low diversity of microbes.
Read more: Dementia: Two types of humor linked to decline
if(typeof utag_data.ads.fb_pixel!==”undefined”&&utag_data.ads.fb_pixel==!0)!function(f,b,e,v,n,t,s)if(f.fbq)return;n=f.fbq=function()n.callMethod?n.callMethod.apply(n,arguments):n.queue.push(arguments);if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′;n.queue=[];t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)(window,document,’script’,’https://connect.facebook.net/en_US/fbevents.js’);fbq(‘init’,’568781449942811′);fbq(‘track’,’PageView’)
(This story has not been edited by seemayo staff and is published from a rss feed)